Laronde is a developer of eRNA (endless RNA) technology to further develop programmable medicines.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
10/19/2023 | Series A Prime | $7.49MM | $xx.xx | $2.62B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,693,610
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
10/19/2023 | Series A Double Prime | $12.17MM | $xx.xx | $2.62B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,221,968
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
10/19/2023 | Series A-2 Prime | $14.87MM | $xx.xx | $2.62B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,233,149
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
10/19/2023 | Series A-2 Double Prime | $10MM | $xx.xx | $2.62B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
500,320
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
10/19/2023 | Series B Prime | $98.66MM | $xx.xx | $2.62B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
4,935,486
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
10/19/2023 | Series BB Prime | $123.4MM | $xx.xx | $2.62B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
4,405,735
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.5x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
08/30/2021 | Series B | $440MM | $xx.xx | $1.59B | Blackrock, Cpp Investments, Federated Hermes Kaufmann Funds, Fidelity, Flagship Pioneering, Invus, T. Rowe Price | |
Price per Share
$xx.xx
Shares Outstanding
15,714,271
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.5x
Dividend Rate
6.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Blackrock, Cpp Investments, Federated Hermes Kaufmann Funds, Fidelity, Flagship Pioneering, Invus, T. Rowe Price
|
||||||
05/10/2021 | Series A | $10.77MM | $xx.xx | $82.96MM | Flagship Pioneering | |
Price per Share
$xx.xx
Shares Outstanding
10,768,827
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Flagship Pioneering
|
||||||
05/10/2021 | Series A-1 | $19.94MM | $xx.xx | $82.96MM | Flagship Pioneering | |
Price per Share
$xx.xx
Shares Outstanding
9,971,837
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Flagship Pioneering
|